N-Cadherin Interacts with Axin and LRP5 To Negatively Regulate Wnt/β-Catenin Signaling, Osteoblast Function, and Bone Formation

ABSTRACT Wnt signaling plays an important role in the regulation of bone formation and bone mass. The mechanisms that regulate canonical Wnt signaling in osteoblasts are not fully understood. We show here a novel mechanism by which the adhesion molecule N-cadherin interacts with the Wnt coreceptor LRP5 and regulates canonical Wnt/β-catenin signaling in osteoblasts. We demonstrate that N-cadherin, besides associating with β-catenin at the membrane, forms a molecular complex with axin and LRP5 involving the LRP5 cytoplasmic tail domain. N-cadherin overexpression in osteoblasts increases N-cadherin-LRP5 interaction, causing increased β-catenin degradation and altered TCF/LEF transcription in response to Wnt3a. This mechanism results in decreased osteoblast gene expression and osteogenesis in basal conditions and in response to Wnt3a. Consistent with a functional mechanism, silencing N-cadherin expression in control cells increases TCF/LEF transcription and enhances the response to Wnt3a. Using N-cadherin transgenic mice, we show that increased N-cadherin-LRP5 interaction resulting from targeted overexpression of N-cadherin in osteoblasts causes increased β-catenin ubiquitination and results in cell-autonomous defective osteoblast function, reduced bone formation, and delayed bone mass acquisition. These data indicate that a previously unrecognized N-cadherin-axin-LRP5 interaction negatively regulates Wnt/β-catenin signaling and is critical in the regulation of osteoblast function, bone formation, and bone mass.

[1]  Ralph Müller,et al.  Automated compartmental analysis for high-throughput skeletal phenotyping in femora of genetic mouse models. , 2007, Bone.

[2]  Christof Niehrs,et al.  Wnt Induces LRP6 Signalosomes and Promotes Dishevelled-Dependent LRP6 Phosphorylation , 2007, Science.

[3]  R. Baron,et al.  Wnt signaling and the regulation of bone mass , 2007, Current osteoporosis reports.

[4]  G. Karsenty,et al.  In vivo analysis of Wnt signaling in bone. , 2007, Endocrinology.

[5]  W. Van Hul,et al.  The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes. , 2007, Endocrinology.

[6]  B. Komm,et al.  Wnt signaling and osteoblastogenesis , 2007, Reviews in Endocrine and Metabolic Disorders.

[7]  Su‐Li Cheng,et al.  Accentuated Ovariectomy‐Induced Bone Loss and Altered Osteogenesis in Heterozygous N‐Cadherin Null Mice , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  R. Civitelli,et al.  Perspective: Cell–Cell Adhesion and Signaling Through Cadherins: Connecting Bone Cells in Their Microenvironment , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  O. MacDougald,et al.  Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.

[10]  S. Roman-Roman,et al.  Wnt signalling pathway: a new target for the treatment of osteoporosis , 2005, Expert opinion on therapeutic targets.

[11]  Xi He,et al.  SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor* , 2005, Journal of Biological Chemistry.

[12]  R. Baron,et al.  Interaction between LRP5 and Frat1 Mediates the Activation of the Wnt Canonical Pathway* , 2005, Journal of Biological Chemistry.

[13]  B. Geiger,et al.  Signaling from adherens-type junctions. , 2005, European journal of cell biology.

[14]  Su‐Li Cheng,et al.  β‐Catenin and BMP‐2 synergize to promote osteoblast differentiation and new bone formation , 2005, Journal of cellular biochemistry.

[15]  J. Westendorf,et al.  Wnt signaling in osteoblasts and bone diseases. , 2004, Gene.

[16]  Feng Cong,et al.  Wnt signals across the plasma membrane to activate the β-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP , 2004, Development.

[17]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[18]  Su‐Li Cheng,et al.  Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis , 2004, Journal of Cell Science.

[19]  R. Krumlauf,et al.  Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex , 2004, Development.

[20]  R. Nusse,et al.  Convergence of Wnt, ß-Catenin, and Cadherin Pathways , 2004, Science.

[21]  Xi He,et al.  A mechanism for Wnt coreceptor activation. , 2004, Molecular cell.

[22]  Keith R. Johnson,et al.  Cadherin-mediated cellular signaling. , 2003, Current opinion in cell biology.

[23]  Alison Rowe,et al.  Wise, a context-dependent activator and inhibitor of Wnt signalling , 2003, Development.

[24]  Yoshiaki Kawano,et al.  Secreted antagonists of the Wnt signalling pathway , 2003, Journal of Cell Science.

[25]  J. A. Robinson,et al.  High Bone Mass in Mice Expressing a Mutant LRP5 Gene , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  Gideon A. Rodan,et al.  Control of osteoblast function and regulation of bone mass , 2003, Nature.

[27]  Eric Wieschaus,et al.  Wg/Wnt signal can be transmitted through arrow/LRP5,6 and Axin independently of Zw3/Gsk3beta activity. , 2003, Developmental cell.

[28]  J. Lilien,et al.  PTP1B Modulates the Association of β-Catenin with N-cadherin through Binding to an Adjacent and Partially Overlapping Target Site* , 2002, The Journal of Biological Chemistry.

[29]  L. Hofbauer,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[30]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[31]  Avri Ben-Ze'ev,et al.  The cadherin-catenin adhesion system in signaling and cancer. , 2002, The Journal of clinical investigation.

[32]  Ivan Lobov,et al.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.

[33]  E. Wagner,et al.  Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.

[34]  P. Marie Role of N‐cadherin in bone formation , 2002, Journal of cellular physiology.

[35]  V. Lefebvre,et al.  Regulatory mechanisms in the pathways of cartilage and bone formation. , 2001, Current opinion in cell biology.

[36]  Miikka Vikkula,et al.  LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.

[37]  Stuart A. Aaronson,et al.  Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow , 2001, Nature Cell Biology.

[38]  J. Lemonnier,et al.  Role of N‐Cadherin and Protein Kinase C in Osteoblast Gene Activation Induced by the S252W Fibroblast Growth Factor Receptor 2 Mutation in Apert Craniosynostosis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  J Mao,et al.  Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. , 2001, Molecular cell.

[40]  Su‐Li Cheng,et al.  A Dominant Negative Cadherin Inhibits Osteoblast Differentiation , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  Kathleen E. Rankin,et al.  Regulation of Glycogen Synthase Kinase 3β and Downstream Wnt Signaling by Axin , 1999, Molecular and Cellular Biology.

[42]  J Mao,et al.  Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt‐mediated regulation of LEF‐1 , 1999, The EMBO journal.

[43]  J. Nathans,et al.  A new secreted protein that binds to Wnt proteins and inhibits their activites , 1999, Nature.

[44]  T. Akiyama,et al.  Negative regulation of Wingless signaling by D-axin, a Drosophila homolog of axin. , 1999, Science.

[45]  T. Bouwmeester,et al.  The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals , 1999, Nature.

[46]  S. Sokol,et al.  Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin , 1998, Current Biology.

[47]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[48]  Wei Hsu,et al.  The Mouse Fused Locus Encodes Axin, an Inhibitor of the Wnt Signaling Pathway That Regulates Embryonic Axis Formation , 1997, Cell.

[49]  K. Linask,et al.  N-cadherin-catenin interaction: necessary component of cardiac cell compartmentalization during early vertebrate heart development. , 1997, Developmental biology.

[50]  B. de Crombrugghe,et al.  Identification of a minimal sequence of the mouse pro-alpha 1(I) collagen promoter that confers high-level osteoblast expression in transgenic mice and that binds a protein selectively present in osteoblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[52]  G. Karsenty,et al.  Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. , 2006, Current topics in developmental biology.

[53]  Mark L. Johnson,et al.  Parameters of LRP5 from a structural and molecular perspective. , 2005, Critical reviews in eukaryotic gene expression.

[54]  R. Nusse,et al.  Convergence of Wnt, beta-catenin, and cadherin pathways. , 2004, Science.

[55]  Mark L. Johnson,et al.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.

[56]  P. Marie The Molecular Genetics of Bone Formation , 2001, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[57]  J. Lemonnier,et al.  N- and E-cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein-2. , 2000, Journal of cellular physiology.

[58]  A. Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. , 1998, The EMBO journal.